Insider Transactions in Q4 2024 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Kyle Piskel Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
248
-0.16%
|
$992
$4.98 P/Share
|
|
Oct 08
2024
|
Susan Bobulsky Chief Commercial Officer, MRD |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.94%
|
$5,000
$1.98 P/Share
|